GPR55 Inhibits Inflammatory Factor TNF-α-Mediated RhoA/ROCK2/IκBα/p65 Signaling Pathway to Alleviate Diabetic Cardiomyopathy in Rats
International Journal of General Medicine · 2026-08 · Volume 19 · 1-18
DOI: 10.2147/ijgm.s624354 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of General Medicine, 2026-08. Verfasst von Jing Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Tianjin, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Tianjin, People's Republic of China.
Zitieren
APA
Wang, J., Yang, X., Gao, X., Li, D., & Yao, Z. (2026). GPR55 Inhibits Inflammatory Factor TNF-α-Mediated RhoA/ROCK2/IκBα/p65 Signaling Pathway to Alleviate Diabetic Cardiomyopathy in Rats. International Journal of General Medicine, Volume 19, 1-18. https://doi.org/10.2147/ijgm.s624354
Vancouver
Wang J, Yang X, Gao X, Li D, Yao Z. GPR55 Inhibits Inflammatory Factor TNF-α-Mediated RhoA/ROCK2/IκBα/p65 Signaling Pathway to Alleviate Diabetic Cardiomyopathy in Rats. International Journal of General Medicine. 2026;Volume 19:1-18. doi:10.2147/ijgm.s624354
BibTeX
@article{Wang2026,
author = {Wang, Jing and Yang, Xiaoyu and Gao, Xuemei and Li, Dong and Yao, Zhuhua},
title = {GPR55 Inhibits Inflammatory Factor TNF-α-Mediated RhoA/ROCK2/IκBα/p65 Signaling Pathway to Alleviate Diabetic Cardiomyopathy in Rats},
journal = {International Journal of General Medicine},
year = {2026},
volume = {Volume 19},
pages = {1--18},
doi = {10.2147/ijgm.s624354}
}
EUVIMED